From nature to industry: Harnessing enzymes for biocatalysis
Biocatalysis harnesses enzymes to make valuable products. This green technology is used
in countless applications from bench scale to industrial production and allows practitioners …
in countless applications from bench scale to industrial production and allows practitioners …
Accelerating biocatalysis discovery with machine learning: a paradigm shift in enzyme engineering, discovery, and design
B Markus, K Andreas, K Arkadij, L Stefan, O Gustav… - ACS …, 2023 - ACS Publications
Emerging computational tools promise to revolutionize protein engineering for biocatalytic
applications and accelerate the development timelines previously needed to optimize an …
applications and accelerate the development timelines previously needed to optimize an …
Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry
T Fujii, Y Matsuda - Expert Opinion on Biological Therapy, 2023 - Taylor & Francis
Introduction In the field of bioconjugates, the focus on antibody–drug conjugates (ADCs)
with novel payloads beyond the traditional categories of potent cytotoxic agents is …
with novel payloads beyond the traditional categories of potent cytotoxic agents is …
Multidisciplinary approaches for enzyme biocatalysis in pharmaceuticals: protein engineering, computational biology, and nanoarchitectonics
Enzyme biocatalysis is reshaping pharmaceutical synthesis, offering sustainable and
efficient pathways for drug discovery and production. This paradigm shift towards eco …
efficient pathways for drug discovery and production. This paradigm shift towards eco …
Toward Clinical Applications: Transforming Nonantibiotic Antibacterials into Effective Next-Generation Supramolecular Therapeutics
CKO Dzuvor - ACS nano, 2024 - ACS Publications
Antibiotic resistance is a major driver of morbidity and mortality worldwide, necessitating
alternatives. Due to their mechanism of action, bacteriophages, endolysins, and …
alternatives. Due to their mechanism of action, bacteriophages, endolysins, and …
Modern approaches to therapeutic oligonucleotide manufacturing
Therapeutic oligonucleotides are a powerful drug modality with the potential to treat many
diseases. The rapidly growing number of therapies that have been approved and that are in …
diseases. The rapidly growing number of therapies that have been approved and that are in …
Lipoic Acid Ligase A‐Mediated Ligation: Mechanism, Applications, and Emerging Innovations in Bioconjugation
S Yamazaki, Y Matsuda - ChemistrySelect, 2023 - Wiley Online Library
This review outlines the latest findings on bioconjugation using lipoic acid ligase A (LplA), a
key enzyme that allows the introduction of new functional groups into biomolecules. LplA …
key enzyme that allows the introduction of new functional groups into biomolecules. LplA …
One‐Step Maleimide‐Based Dual Functionalization of Protein N‐Termini
K Hanaya, K Taguchi, Y Wada… - Angewandte Chemie …, 2024 - Wiley Online Library
Maleimide derivatives are privileged reagents for chemically modifying proteins through the
Michael addition reaction with cysteine due to their selectivity, operational simplicity, and …
Michael addition reaction with cysteine due to their selectivity, operational simplicity, and …
Identification of a Novel Transasparaginase Activity of Bacillus subtilis (bTG) for Sequence-Specific Bioconjugation
M Flamme, R Göhring, D Zamarbide… - Bioconjugate …, 2024 - ACS Publications
The ability of Bacillus subtilis transglutaminase (bTG) to functionalize BSA has been
investigated using peptide mapping experiments. Interestingly, the conjugation was not …
investigated using peptide mapping experiments. Interestingly, the conjugation was not …
AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors
L Carmès, G Bort, F Lux, L Seban, P Rocchi… - Nanoscale, 2024 - pubs.rsc.org
This article presents bioconjugates combining nanoparticles (AGuIX) with nanobodies
(VHH) targeting Programmed Death-Ligand 1 (PD-L1, A12 VHH) and Cluster of …
(VHH) targeting Programmed Death-Ligand 1 (PD-L1, A12 VHH) and Cluster of …